CD8A and Burkitt lymphoma: First, we treated Burkitt’s lymphoma cell lines with 10 μM of either iEZH2 or dEZH2 in a co-culture environment with cytotoxic T lymphocytes (CTLs; CD8+ T cells) and assessed PD-L1 expression through flow cytometry.